Drug Delivery Business

How CGM tech has advanced in the 21st century

By

Dexcom Seven CGM
Dexcom’s Seven CGM stretched monitoring to up to seven days. [Image courtesy of Dexcom]

Packaging with insulin pumps — and extending monitoring time

2006: Medtronic debuts first integrated insulin pump and CGM system

Medtronic received FDA approval for its MiniMed Paradigm REAL-Time system, which it described as a milestone toward the development of an artificial pancreas. The following year, the company expanded the indication for its CGMs to include patients aged 7–17.

2007: Dexcom introduces the Seven CGM

The device was the first approved for up to seven days of use. A model with updated software known as the Seven Plus (shown here) introduced blood sugar trending arrows. The trend arrows can help people with diabetes anticipate in advance when blood sugars are starting to trend high or low.

2007: Medtronic launches the Guardian REAL-Time system with MiniLink transmitter

The standalone personal CGM features a smaller transmitter than preceding models. The transmitter is waterproof to a depth of 8 feet for up to 30 minutes when connected to the glucose sensor.

Next>>

IN CASE YOU MISSED IT

About Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.